AQP4-Ab+/ON | AQP4-Ab−/ON | NMO-ON | HCs | p Value* | p Value† | p Value‡ | p Value§ | |
---|---|---|---|---|---|---|---|---|
pRNFL thickness (μm) | 48.61±17.43 | 61.98±20.93 | 47.88±21.16 | 106.15±10.39 | 0.000 | 0.000 | 0.681 | 0.000 |
NS | 53.61±25.80 | 70.77±34.20 | 55.03±30.29 | 120.94±25.04 | 0.000 | 0.001 | 0.657 | 0.014 |
TS | 74.41±30.95 | 86.85±32.91 | 75.41±37.65 | 148.58±20.79 | 0.000 | 0.006 | 0.288 | 0.156 |
N | 29.71±13.21 | 43.05±17.22 | 26.31±17.18 | 67.14±15.10 | 0.000 | 0.000 | 0.242 | 0.000 |
NI | 52.25±19.71 | 75.31±26.39 | 51.00±22.01 | 122.52±24.15 | 0.000 | 0.000 | 0.880 | 0.000 |
TI | 73.64±31.94 | 94.46±39.52 | 72.47±21.36 | 160.95±21.36 | 0.000 | 0.000 | 0.551 | 0.000 |
T | 37.57±14.18 | 41.09±15.84 | 38.28±16.78 | 80.94±13.41 | 0.000 | 0.135 | 0.352 | 0.699 |
Segmented macular layers volume (mm3) | ||||||||
mRNFL | 0.482±0.109 | 0.544±0.126 | 0.494±0.129 | 0.853±0.201 | 0.000 | 0.009 | 0.802 | 0.032 |
RGCL | 0.643±0.135 | 0.686±0.153 | 0.661±0.175 | 1.144±0.101 | 0.000 | 0.106 | 0.583 | 0.374 |
IPL | 0.637±0.773 | 0.690±0.093 | 0.645±0.094 | 0.931±0.063 | 0.000 | 0.000 | 0.624 | 0.006 |
INL | 1.099±0.088 | 1.083±0.137 | 1.128±0.147 | 1.041±0.067 | 0.000 | 0.353 | 0.252 | 0.043 |
Significance of bold fonts: p values <0.05.
*Comparison in AQP4-Ab+/ON, AQP4-Ab−/ON, NMO-ON and HCs.
†AQP4-Ab+/ON versus AQP4-Ab−/ON.
‡AQP4-Ab+ON versus NMO-ON.
§AQP4-Ab−/ON versus NMO-ON.
AQP4-Ab−/ON, optic neuritis with AQP4-Ab seronegativity; AQP4-Ab+/ON, optic neuritis with AQP4-Ab seropositivity; HCs, healthy controls; INL, inner nuclear layer; IPL, inner plexiform layer; mRNFL, macular retinal nerve fibre layer; N, nasal quadrant of pRNFL; NI, nasal inferior quadrant of pRNFL; NMO-ON, neuromyelitis optica with optic nerve affected; NS, nasal superior quadrant of pRNFL; pRNFL, peripapillary retinal nerve fibre layer; RGCL, retinal ganglion cell layer; T, temporal; TI, temporal inferior quadrant of pRNFL; TS, temporal superior quadrant of pRNFL.